Randy Berholtz - Net Worth and Insider Trading

Randy Berholtz Net Worth

The estimated net worth of Randy Berholtz is at least $3,352 dollars as of 2024-05-19. Randy Berholtz is the EVP, CORPORATE DEVELOPMENT of Innovus Pharmaceuticals Inc and owns about 161 shares of Innovus Pharmaceuticals Inc (INNV) stock worth over $3,352. Details can be seen in Randy Berholtz's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Randy Berholtz has not made any transactions after 2017-11-22 and currently still holds the listed stock(s).

Transaction Summary of Randy Berholtz

To

Randy Berholtz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Randy Berholtz owns 3 companies in total, including Innovus Pharmaceuticals Inc (INNV) , Life On Earth Inc (LFER) , and Seelos Therapeutics Inc (SEEL) .

Click here to see the complete history of Randy Berholtz’s form 4 insider trades.

Insider Ownership Summary of Randy Berholtz

Ticker Comapny Transaction Date Type of Owner
INNV Innovus Pharmaceuticals Inc 2018-04-05 EVP & CORPORATE DEVELOPMENT
LFER Life On Earth Inc 2017-01-06 director
SEEL Seelos Therapeutics Inc 2011-05-09 Executive VP & General Counsel

Randy Berholtz Latest Holdings Summary

Randy Berholtz currently owns a total of 1 stock. Randy Berholtz owns 161 shares of Innovus Pharmaceuticals Inc (INNV) as of November 22, 2017, with a value of $3,352.

Latest Holdings of Randy Berholtz

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INNV Innovus Pharmaceuticals Inc 2017-11-22 161 20.82 3,352

Holding Weightings of Randy Berholtz


Randy Berholtz Form 4 Trading Tracker

According to the SEC Form 4 filings, Randy Berholtz has made a total of 0 transactions in Innovus Pharmaceuticals Inc (INNV) over the past 5 years. The most-recent trade in Innovus Pharmaceuticals Inc is the acquisition of 161 shares on November 22, 2017, which cost Randy Berholtz around $1,688.

Insider Trading History of Randy Berholtz

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Randy Berholtz Trading Performance

GuruFocus tracks the stock performance after each of Randy Berholtz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Randy Berholtz is 83.32%. GuruFocus also compares Randy Berholtz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Randy Berholtz within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Randy Berholtz's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Randy Berholtz

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.44
Relative Return to S&P 500(%) -17.76

Randy Berholtz Ownership Network

Ownership Network List of Randy Berholtz

No Data

Ownership Network Relation of Randy Berholtz


Randy Berholtz Owned Company Details

What does Innovus Pharmaceuticals Inc do?

Who are the key executives at Innovus Pharmaceuticals Inc?

Randy Berholtz is the EVP & CORPORATE DEVELOPMENT of Innovus Pharmaceuticals Inc. Other key executives at Innovus Pharmaceuticals Inc include 10 percent owner Armistice Capital, Llc , 10 percent owner Armistice Capital Master Fund Ltd. , and 10 percent owner Steven Boyd .

Innovus Pharmaceuticals Inc (INNV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Innovus Pharmaceuticals Inc (INNV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Innovus Pharmaceuticals Inc (INNV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Innovus Pharmaceuticals Inc (INNV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovus Pharmaceuticals Inc Insider Transactions

No Available Data

Randy Berholtz Mailing Address

Above is the net worth, insider trading, and ownership report for Randy Berholtz. You might contact Randy Berholtz via mailing address: 6330 Nancy Ridge Drive, Suite 103, San Diego Ca 92121.

Discussions on Randy Berholtz

No discussions yet.